Ishikawa K - Search Results

1

Translational Aspects of Adeno-Associated Virus-Mediated Cardiac Gene Therapy.

Ziegler T, Ishikawa K, Hinkel R, Kupatt C. Ziegler T, et al. Among authors: ishikawa k. Hum Gene Ther. 2018 Dec;29(12):1341-1351. doi: 10.1089/hum.2017.229. Epub 2018 Jul 24. Hum Gene Ther. 2018. PMID: 29848073 Review.

2

Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model.

Ladage D, Turnbull IC, Ishikawa K, Takewa Y, Rapti K, Morel C, Karakikes I, Hadri L, Müller-Ehmsen J, Costa KD, Hajjar RJ, Kawase Y. Ladage D, et al. Among authors: ishikawa k. Gene Ther. 2011 Oct;18(10):979-85. doi: 10.1038/gt.2011.52. Epub 2011 Apr 21. Gene Ther. 2011. PMID: 21512506 Free PMC article.

3

Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models.

Rapti K, Louis-Jeune V, Kohlbrenner E, Ishikawa K, Ladage D, Zolotukhin S, Hajjar RJ, Weber T. Rapti K, et al. Among authors: ishikawa k. Mol Ther. 2012 Jan;20(1):73-83. doi: 10.1038/mt.2011.177. Epub 2011 Sep 13. Mol Ther. 2012. PMID: 21915102 Free PMC article.

4

Gene delivery methods in cardiac gene therapy.

Ishikawa K, Tilemann L, Fish K, Hajjar RJ. Ishikawa K, et al. J Gene Med. 2011 Oct;13(10):566-72. doi: 10.1002/jgm.1609. J Gene Med. 2011. PMID: 21954037 Review.

5

Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts.

Karakikes I, Hadri L, Rapti K, Ladage D, Ishikawa K, Tilemann L, Yi GH, Morel C, Gwathmey JK, Zsebo K, Weber T, Kawase Y, Hajjar RJ. Karakikes I, et al. Among authors: ishikawa k. Mol Ther. 2012 Mar;20(3):565-71. doi: 10.1038/mt.2011.268. Epub 2012 Jan 3. Mol Ther. 2012. PMID: 22215018 Free PMC article.

6

Cardiac gene therapy in large animals: bridge from bench to bedside.

Ishikawa K, Tilemann L, Ladage D, Aguero J, Leonardson L, Fish K, Kawase Y. Ishikawa K, et al. Gene Ther. 2012 Jun;19(6):670-7. doi: 10.1038/gt.2012.3. Epub 2012 Feb 2. Gene Ther. 2012. PMID: 22301438 Review.

7

Percutaneous methods of vector delivery in preclinical models.

Ladage D, Ishikawa K, Tilemann L, Müller-Ehmsen J, Kawase Y. Ladage D, et al. Among authors: ishikawa k. Gene Ther. 2012 Jun;19(6):637-41. doi: 10.1038/gt.2012.14. Epub 2012 Mar 15. Gene Ther. 2012. PMID: 22418064 Review.

8

Percutaneous approaches for efficient cardiac gene delivery.

Ishikawa K, Aguero J, Naim C, Fish K, Hajjar RJ. Ishikawa K, et al. J Cardiovasc Transl Res. 2013 Aug;6(4):649-59. doi: 10.1007/s12265-013-9479-7. Epub 2013 Jun 8. J Cardiovasc Transl Res. 2013. PMID: 23749638 Review.

9

Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure.

Ishikawa K, Fish KM, Tilemann L, Rapti K, Aguero J, Santos-Gallego CG, Lee A, Karakikes I, Xie C, Akar FG, Shimada YJ, Gwathmey JK, Asokan A, McPhee S, Samulski J, Samulski RJ, Sigg DC, Weber T, Kranias EG, Hajjar RJ. Ishikawa K, et al. Mol Ther. 2014 Dec;22(12):2038-2045. doi: 10.1038/mt.2014.127. Epub 2014 Jul 15. Mol Ther. 2014. PMID: 25023328 Free PMC article.

10

Adeno-associated virus-mediated gene therapy in cardiovascular disease.

Hammoudi N, Ishikawa K, Hajjar RJ. Hammoudi N, et al. Among authors: ishikawa k. Curr Opin Cardiol. 2015 May;30(3):228-34. doi: 10.1097/HCO.0000000000000159. Curr Opin Cardiol. 2015. PMID: 25783685 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,381 results

Search Page